Piper Sandler Upgrades Alkermes to Overweight, Raises Price Target to $30
Piper Sandler analyst David Amsellem upgrades Alkermes (NASDAQ:ALKS) from Neutral to Overweight and raises the price target from $26 to $30.
Baird Upgrades Mayville Engineering to Outperform, Announces $15 Price Target
Baird analyst Mircea Dobre upgrades Mayville Engineering (NYSE:MEC) from Neutral to Outperform and announces $15 price target.
William Blair Upgrades Lindblad Expeditions to Outperform
William Blair analyst Ryan Sundby upgrades Lindblad Expeditions (NASDAQ:LIND) from Market Perform to Outperform.
Ladenburg Thalmann Upgrades Gladstone Inv to Buy, Announces $14 Price Target
Ladenburg Thalmann analyst Mickey Schleien upgrades Gladstone Inv (NASDAQ:GAIN) from Neutral to Buy and announces $14 price target.
Evercore ISI Group Upgrades BioCryst Pharmaceuticals to Outperform, Announces $16 Price Target
Evercore ISI Group analyst Liisa Bayko upgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from In-Line to Outperform and announces $16 price target.
Exane BNP Paribas Upgrades Exxon Mobil to Neutral, Announces $115 Price Target
Exane BNP Paribas analyst Lucas Herrmann upgrades Exxon Mobil (NYSE:XOM) from Underperform to Neutral and announces $115 price target.
Guggenheim Upgrades AnaptysBio to Buy
Guggenheim analyst Yatin Suneja upgrades AnaptysBio (NASDAQ:ANAB) from Neutral to Buy.
Barclays Upgrades First Solar to Equal-Weight, Raises Price Target to $162
Barclays analyst Christine Cho upgrades First Solar (NASDAQ:FSLR) from Underweight to Equal-Weight and raises the price target from $89 to $162.
Morgan Stanley Upgrades Gogo to Equal-Weight, Raises Price Target to $15
Morgan Stanley analyst Landon Park upgrades Gogo (NASDAQ:GOGO) from Underweight to Equal-Weight and raises the price target from $14 to $15.
JP Morgan Upgrades Lennox International to Neutral, Raises Price Target to $226
JP Morgan analyst Stephen Tusa upgrades Lennox International (NYSE:LII) from Underweight to Neutral and raises the price target from $210 to $226.